MED-CHAINS & COVID – 19

MED-CHAINS & COVID – 19
Author: Ebot Eyong
Publisher: E&E Medicals
Total Pages: 135
Release: 2020-12-07
Genre: Antiques & Collectibles
ISBN:

MED-CHAINS & COVID – 19: Innovative Solutions for Pandemics is the groundbreaking new book by Dr. Eyong, offering the medical community new insight into COVID-19 and previous pandemics. Rather than quarreling over the inadequacies and inconsistencies of current pandemic practices, Dr. Eyong’s new book offers his tangible and innovative solutions on how to approach, analyze and handle a pandemic crisis. His thoroughly researched approach to pandemics employs the expertise of respected medical researchers, acclaimed scientists, and innovative medical device developers across the industry. By employing their combined medical wisdom, Dr. Eyong provides feasible solutions for preparing, managing, and the ultimate goal of preventing a pandemic, such as COVID-19, from occurring in the future. This book will be available in ten languages: English, French, Spanish, German, Portuguese, Chinese, Russian, Arabic, Latin, and Japanese.

MED-CHAINS & COVID – 19: Innovative Solutions for Pandemics (Japanese Version)

MED-CHAINS & COVID – 19: Innovative Solutions for Pandemics (Japanese Version)
Author: Ebot Eyong
Publisher: E&E Medicals
Total Pages: 218
Release:
Genre: Antiques & Collectibles
ISBN:

MED-CHAINS & COVID – 19: Innovative Solutions for Pandemics is the groundbreaking new book by Dr. Eyong, offering the medical community new insight into COVID-19 and previous pandemics. Rather than quarreling over the inadequacies and inconsistencies of current pandemic practices, Dr. Eyong’s new book offers his tangible and innovative solutions on how to approach, analyze, and handle a pandemic crisis. His thoroughly researched approach to pandemics employs the expertise of respected medical researchers, acclaimed scientists, and innovative medical device developers across the industry. By employing their combined medical wisdom, Dr. Eyong provides feasible solutions for preparing, managing, and the ultimate goal of preventing a pandemic, such as COVID-19, from occurring in the future. This book will be available in ten languages: English, French, Spanish, German, Portuguese, Chinese, Russian, Arabic, Latin, and Japanese.

MED-CHAINS & COVID – 19: Innovative Solutions for Pandemics

MED-CHAINS & COVID – 19: Innovative Solutions for Pandemics
Author: Ebot Eyong
Publisher: E&E Medicals
Total Pages: 153
Release: 2020-12-18
Genre: Antiques & Collectibles
ISBN: 1637323875

MED-CHAINS & COVID – 19: Innovative Solutions for Pandemics is the groundbreaking new book by Dr. Eyong, offering the medical community new insight into COVID-19 and previous pandemics. Rather than quarreling over the inadequacies and inconsistencies of current pandemic practices, Dr. Eyong’s new book offers his tangible and innovative solutions on how to approach, analyze and handle a pandemic crisis. His thoroughly researched approach to pandemics employs the expertise of respected medical researchers, acclaimed scientists, and innovative medical device developers across the industry. By employing their combined medical wisdom, Dr. Eyong provides feasible solutions for preparing, managing, and the ultimate goal of preventing a pandemic, such as COVID-19, from occurring in the future. This book will be available in ten languages: English, French, Spanish, German, Portuguese, Chinese, Russian, Arabic, Latin, and Japanese.

COVID-19

COVID-19
Author: Karen M. Sutter
Publisher:
Total Pages: 53
Release: 2020
Genre: COVID-19 (Disease)
ISBN:

Supply Chain Immunity

Supply Chain Immunity
Author: Robert Handfield
Publisher: Springer Nature
Total Pages: 136
Release: 2023-03-02
Genre: Business & Economics
ISBN: 303119344X

This book provides a concerted supply chain perspective for dealing with pandemics on the scale of COVID-19. Specifically, this book describes a new approach, supply chain immunity, to illustrate what is needed to fix our economy and healthcare systems. The authors of this book are experts in supply chain management, health care supply chains, major systems acquisition, and contingency sourcing methods. Based on first-hand experiences working during COVID in the depths of the nation’s supply chain failures, the authors develop important themes for private and public sector supply chain managers to consider in rebuilding a more immune supply chain. The book is targeted at policy makers, academics, practitioners, and students of disaster response, public policy, healthcare, and supply chain management who are interested in learning contemporary lessons from the COVID-19 pandemic. From the perspective of those who lived through the chaos, the authors further explore the application of novel concepts in joint planning, market intelligence, and governance related to a national pandemic or other global contingency.

Science-Based Approaches to Respond to COVID and Other Public Health Threats

Science-Based Approaches to Respond to COVID and Other Public Health Threats
Author: Erick Guerrero
Publisher: BoD – Books on Demand
Total Pages: 282
Release: 2021-12-01
Genre: Medical
ISBN: 1839691433

COVID-19 and other public health threats have contributed to more than six million deaths globally in a short amount of time. As such, there is an urgent need to respond to these threats in a way that improves global health and wellbeing. Written by a diverse group of exemplary scientists, the thirteen chapters in this volume provide unique, comprehensive, and science-based approaches to respond to macro-structural, human process, and micro issues affecting public health threats.

The New (Ab)Normal

The New (Ab)Normal
Author: Yossi Sheffi
Publisher: MIT CTL Media
Total Pages: 271
Release: 2020-10-01
Genre: Business & Economics
ISBN: 1735766127

Much has been written about Covid-19 victims, how scientists raced to understand and treat the disease, and how governments did (or did not) protect their citizens. Less has been written about the pandemic’s impact on the global economy and how companies coped as the competitive environment was upended. In his new book, "The New (Ab)Normal", MIT Professor Yossi Sheffi maps how the Covid-19 pandemic impacted business, supply chains, and society. He exposes the critical role supply chains play in helping people, governments, and companies to manage the crisis. The book draws on executive interviews, pandemic media coverage, and historical analyses. Sheffi also builds on themes from his books "The Resilient Enterprise" (2005) and "The Power of Resilience" (2015) to enrich the narrative. The author paints a compelling picture of how the Covid-19 virus is changing many facets of human life and what our post-pandemic world might look like. This must-read book helps companies to redefine their business models and adjust to a fast-evolving economic landscape. The stage is set In Part 1 of the book, “What Happened,” the author looks at how companies fought to mend the global economic fabric even as the virus ripped more holes in it. Part 2, “Living with Uncertainty,” views the crisis through a supply chain risk management lens derived from Yossi Sheffi’s previous books. This perspective shows how companies create corporate immune systems to quickly recognize and manage large-scale disruptions. The ongoing pandemic is creating a new normal in life, work, and education—covered in Part 3, “Adjustment Required.” Consumer fears about the contagion as well as government mandates require businesses in industries such as retail, hospitality, entertainment, sports, and education to create “safe zones” for workers and customers. Many elements of the book – especially in Part 4, “Supply Chains for the Future” – show how the virus accelerated preexisting trends in technology adoption. China was the epicenter of the pandemic; it also was the first nation to be disrupted and recover. Part 5 of the book, “Of Politics and Pandemics,” explains why reports that companies are abandoning China in favor of other offshore manufacturing centers do not reflect reality. Fundamentally, The New (Ab)Normal is about businesses trying to create a better future in a time of extreme uncertainty – a point emphasized in Part 6, “The Next Opportunities.” The outlook is not necessarily gloomy. The advance of technology is accelerating, a trend that can level the playing field between small and large companies. Nimble small businesses are using a growing array of off-the-shelf cloud computing and mobile apps to deploy sophisticated technologies in their supply chains and customer interfaces. The New (Ab)Normal Another new normal is working from home. Remote working enables individuals to live anywhere and companies to recruit talent from anywhere. Education, especially higher education, faces a major disruption (and major opportunity) that is likely to shake the high-cost model of in-person education in favor of online or hybrid education. Regrettably, the book recognizes one trend accentuated by Covid-19--the growing inequality, and anticipates that the new normal will be more stratified.

China Rx

China Rx
Author: Rosemary Gibson
Publisher: Prometheus Books
Total Pages: 306
Release: 2018
Genre: Business & Economics
ISBN: 1633883817

Millions of Americans are taking prescription drugs made in China and don't know it-- and pharmaceutical companies are not eager to tell them. This probing book examines the implications for the quality and availability of vital medicines for consumers. Several decades ago, penicillin, vitamin C, and many other prescription and over-the-counter products were manufactured in the United States. But with the rise of globalization, antibiotics, antidepressants, birth control pills, blood pressure medicines, cancer drugs, among many others are made in China and sold in the United States. China's biggest impact on the US drug supply is making essential ingredients for thousands of medicines found in American homes and used in hospital intensive care units and operating rooms. The authors convincingly argue that there are at least two major problems with this scenario. First, it is inherently risky for the United States to become dependent on any one country as a source for vital medicines, especially given the uncertainties of geopolitics. For example, if an altercation in the South China Sea causes military personnel to be wounded, doctors may rely upon medicines with essential ingredients made by the adversary. Second, lapses in safety standards and quality control in Chinese manufacturing are a risk. Citing the concerns of FDA officials and insiders within the pharmaceutical industry, the authors document incidents of illness and death caused by contaminated medications that prompted reform. This is a disturbing, well-researched book and a wake-up call for improving the current system of drug supply and manufacturing.